Skip to main content

Table 2 Clinical characteristics of 61 participants

From: Analysis of different adipose depot gene expression in cachectic patients with gastric cancer

Clinical characteristics

IRX1

p Value

High (n = 37)

Low (n = 24)

Age

64.71 ± 9.06

65.79 ± 8.38

0.633

BMI

20.36 ± 2.12

22.82 ± 1.61

0.006*

Weight loss

6.53 ± 2.19

5.12 ± 1.93

0.015*

Disease stage (III/IV)

23/37

14/24

0.772

IL6 (mmol/L)

10.67 ± 5.87

7.52 ± 4.38

0.027*

TNFa (mmol/L)

14.24 ± 6.36

11.80 ± 4.11

0.019*

Alb (g/L)

37.89 ± 3.43

39.04 ± 4.45

0.261

PAb (mg/L)

207.59 ± 52.98

220.17 ± 58.42

0.093

FAA (mmol/L)

0.58 ± 0.13

0.53 ± 0.17

0.098

TC (mmol/L)

4.01 ± 0.95

4.26 ± 1.05

0.351

TG (mmol/L)

1.07 ± 0.41

1.10 ± 0.37

0.829

LDL (mmol/L)

2.37 ± 0.84

2.60 ± 0.91

0.317

HDL (mmol/L)

1.18 ± 0.36

1.25 ± 0.57

0.599

ApoA (g/L)

1.16 ± 0.28

1.13 ± 0.26

0.445

ApoB (g/L)

0.79 ± 0.25

0.85 ± 0.21

0.268

ApoE (mg/L)

35.78 ± 14.30

39.06 ± 16.10

0.156

SAT area (cm2)

108.54 ± 19.18

127.09 ± 24.13

< 0.001*

VAT area (cm2)

87.83 ± 17.78

101.09 ± 19.85

0.015*

  1. BMI Body mass index, ALB Albumin, PAb Prealbumin, TC Total cholesterol, TG Tri-glyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid, IL-6 Interleukin 6, TNF-α Tumor necrosis factor-α
  2. * p < 0.05
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us